Argobio Studio is the launch platform for Europe’s best medicinal science. We are operational venture builders dedicated to turning cutting-edge science into globally competitive European companies pioneering breakthrough therapeutics for patients around the world. Argobio reduces execution risk by co-founding, investing, and embedding its experienced collaborative team to accelerate development with industrial rigor and speed toward value-creating milestones.
| Website | https://www.argobiostudio.com/ |
| Employees | 19 (7 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Novel Therapeutics, Biotechnology, Therapeutics, Drug Development, Pharmaceutical, Scientific Research, Academic Research, Life Sciences, Medical Research, Biotech Incubator, Innovative Therapies, Early Stage Biotech, Clinical Trials, New Drugs, Healthcare Innovation, Pharmaceutical Research |
| Competitors | Bayer, BASF, Dow, Syngenta, Corteva Agriscience, FMC Corporation, Nufarm, Novozymes, Monsanto Company Named +34 more (view full list) |
Looking for a particular ARGOBIO employee's phone or email?
Daniel Sobral is the Chief Financial Officer | Head of Corporate Development of ARGOBIO.
7 people are employed at ARGOBIO.